Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Twist Bioscience CorpTWST · Entity 3619 | Chief Financial Officer | January 02, 2024 | January 04, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Twist Bioscience Corp
Report date January 02, 2024 · Filed January 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 86,334 |
Reported balance
After 2024-01-02 transaction · row 1
1 source rowRow 1 · 2024-01-02 · Tax withholding · Disposed 382 · Balance 86,334 F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
IXYS, LLC
Report date January 17, 2018 · Filed January 18, 2018
Section 16 reporting ended · disclosed 2018-01-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-01-17 transaction · row 1
1 source rowRow 1 · 2018-01-17 · Disposition to issuer · Disposed 5,172 · Balance 0 F1: Disposed of pursuant to the closing of the transactions contemplated by that certain Agreement and Plan of Merger, dated as of August 25, 2017 by and among the Issuer, Littelfuse, Inc. ("Littelfuse"), and Iron Merger Co., Inc. (as amended by Amendment No. 1, dated December 4, 2017, by and among the Issuer, Littelfuse, Iron Merger Co., Inc. and IXYS Merger Co., LLC) (the "Merger"). Each share of Issuer common stock held by the reporting person was cancelled in the Merger and converted into the right to receive, at the election of the holder and subject to proration, (i) $23.00 in cash per share, without interest and less any applicable withholding taxes or (ii) 0.1265 shares of Littelfuse common stock. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.83 · Expires 2024-08-28 | Direct | 0 |
Reported balance
After 2018-01-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-01-17 · Disposition to issuer · Disposed 5,000 · Balance 0 F2: Disposed of pursuant to the Merger. Each outstanding and unexercised option to purchase the Issuer's common stock held by the non-employee directors of the Issuer was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product of (x) the excess, if any, of the product of (i) 0.1265 and (ii) $210.77, which is the closing price per share on January 17, 2018 of Littlefuse common stock as reported on the Nasdaq Global Select Market, over the exercise price per share of such option and (y) the number of shares subject to such option. F3: The option is fully vested and exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.14 · Expires 2025-08-28 | Direct | 0 |
Reported balance
After 2018-01-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-01-17 · Disposition to issuer · Disposed 5,000 · Balance 0 F2: Disposed of pursuant to the Merger. Each outstanding and unexercised option to purchase the Issuer's common stock held by the non-employee directors of the Issuer was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product of (x) the excess, if any, of the product of (i) 0.1265 and (ii) $210.77, which is the closing price per share on January 17, 2018 of Littlefuse common stock as reported on the Nasdaq Global Select Market, over the exercise price per share of such option and (y) the number of shares subject to such option. F3: The option is fully vested and exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.58 · Expires 2026-08-26 | Direct | 0 |
Reported balance
After 2018-01-17 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-01-17 · Disposition to issuer · Disposed 5,000 · Balance 0 F2: Disposed of pursuant to the Merger. Each outstanding and unexercised option to purchase the Issuer's common stock held by the non-employee directors of the Issuer was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product of (x) the excess, if any, of the product of (i) 0.1265 and (ii) $210.77, which is the closing price per share on January 17, 2018 of Littlefuse common stock as reported on the Nasdaq Global Select Market, over the exercise price per share of such option and (y) the number of shares subject to such option. F3: The option is fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the closing of the transactions contemplated by that certain Agreement and Plan of Merger, dated as of August 25, 2017 by and among the Issuer, Littelfuse, Inc. ("Littelfuse"), and Iron Merger Co., Inc. (as amended by Amendment No. 1, dated December 4, 2017, by and among the Issuer, Littelfuse, Iron Merger Co., Inc. and IXYS Merger Co., LLC) (the "Merger"). Each share of Issuer common stock held by the reporting person was cancelled in the Merger and converted into the right to receive, at the election of the holder and subject to proration, (i) $23.00 in cash per share, without interest and less any applicable withholding taxes or (ii) 0.1265 shares of Littelfuse common stock.
F2: Disposed of pursuant to the Merger. Each outstanding and unexercised option to purchase the Issuer's common stock held by the non-employee directors of the Issuer was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product of (x) the excess, if any, of the product of (i) 0.1265 and (ii) $210.77, which is the closing price per share on January 17, 2018 of Littlefuse common stock as reported on the Nasdaq Global Select Market, over the exercise price per share of such option and (y) the number of shares subject to such option.
F3: The option is fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2017 Filed Feb 9, 2017 19:58 UTC | IXYS, LLC IXYS · Entity 170247 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001209191-17-009318 · doc4.xml · derivative · entry 5 THORBURN JAMES M · CIK 0001252038 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 5,000 shares Expires 2018-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2017 Filed Feb 9, 2017 19:58 UTC | IXYS, LLC IXYS · Entity 170247 | SaleCommon Stock | 5,000 | $13.18 | $65,903.50 |
DisclosureSEC source: 0001209191-17-009318 · doc4.xml · nonDerivative · entry 4 THORBURN JAMES M · CIK 0001252038 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,172 F2 · price: The shares were sold in multiple trades at prices ranging from $13.10 to $13.25. The price reported above is the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the shares were sold upon receipt of a request from the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| February 09, 2017 Filed Feb 9, 2017 19:58 UTC | IXYS, LLC IXYS · Entity 170247 | Exercise / conversionCommon Stock | 5,000 | $9.45 | $47,250.00 |
DisclosureSEC source: 0001209191-17-009318 · doc4.xml · nonDerivative · entry 3 THORBURN JAMES M · CIK 0001252038 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2017 Filed Feb 9, 2017 19:58 UTC | IXYS, LLC IXYS · Entity 170247 | SaleCommon Stock | 5,000 | $13.25 | $66,252.50 |
DisclosureSEC source: 0001209191-17-009318 · doc4.xml · nonDerivative · entry 2 THORBURN JAMES M · CIK 0001252038 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,172 F1 · price: The shares were sold in multiple trades at prices ranging from $13.25 to $13.2762. The price reported above is the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the shares were sold upon receipt of a request from the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| February 09, 2017 Filed Feb 9, 2017 19:58 UTC | IXYS, LLC IXYS · Entity 170247 | Exercise / conversionCommon Stock | 5,000 | $11.50 | $57,500.00 |
DisclosureSEC source: 0001209191-17-009318 · doc4.xml · nonDerivative · entry 1 THORBURN JAMES M · CIK 0001252038 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.